Injectable Anesthetic Solution Recalled for Lack of Sterility Assurance
Pine Pharmaceuticals is recalling Bupivacaine and Lidocaine injectable solutions for eye anesthesia due to lack of assurance of sterility. The product was distributed to direct accounts in four states.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable pharmaceutical lacking sterility assurance. While no adverse events are reported in the source, the potential for contamination in an injectable product poses significant risk of harm.
Plain-English summary
Pine Pharmaceuticals, LLC is recalling Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or Peribulbar Injection (Rx only) due to lack of assurance of sterility. The affected product is distributed in two prefilled syringe sizes: 10 mL (Item# 803, barcode 6919408031) and 5 mL (Item# 933, barcode 6919409331). A total of 4,183 syringes were distributed to direct accounts.
Distribution was limited to Alabama, California, North Carolina, and New York. The affected lot numbers are 58366, 60247, 54825, 57583, 59343, and 60355, with expiration dates ranging from August 2022 to December 2022.
This is a prescription-only injectable anesthetic used for eye procedures. The FDA has classified this as a Class II recall. Individuals who have used or have access to affected lots should consult with their healthcare provider.
The recalled product
- Product
- Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or Peribulbar Injection; packaged in a) 10 mL prefilled syringe, Item# 803, barcode 6919408031; b) 5 mL prefilled syringe, Item# 933, barcode 6919409331, Rx only, Pine Pharmaceuticals, 355 Riverwalk Park
- Manufacturer
- Pine Pharmaceuticals, LLC
- Category
- Drug — Ophthalmic Injectable
- Hazard
- sterility-failure
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot #s: a) 58366
- exp. date 09/26/2022
- 60247
- exp. date 12/04/2022
- b) 54825
- exp. date 08/10/2022
- 57583
- exp. date 08/22/2022
- 59343
- exp. date 10/30/2022
- 60355
- exp. date 10/11/2022
Distribution
Distributed in 4 states:
- AL
- CA
- NC
- NY
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27